Technology
Health
Biotechnology

Genomic Health

$71.38
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.70 (0.99%) Today
+$0.70 (0.99%) Today

Why Robinhood?

You can buy or sell Genomic Health and other stocks, options, ETFs, and crypto commission-free!

About

Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. Read More The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. Genomic Health was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA.

Employees
829
Headquarters
Redwood City, California
Founded
2000
Market Cap
2.57B
Price-Earnings Ratio
105.70
Dividend Yield
0.00
Average Volume
351.07K
High Today
$72.03
Low Today
$70.74
Open Price
$71.38
Volume
58.04K
52 Week High
$92.18
52 Week Low
$30.04

Collections

Technology
Health
Biotechnology
Medical
US
North America
Female CEOs

News

Yahoo FinanceMar 25

Here's Why You Should Invest in Genomic Health (GHDX) Now

Genomic Health, Inc. GHDX has been gaining investors’ confidence on continued positive results. Over the past year, the stock has outperformed its industry. The stock has gained 118.8% against the industry’s 16.4% fall and the S&P 500’s 6.4% rise. This renowned global cancer company, with a focus on advanced molecular diagnostics, has a market cap of $2.56 billion. With solid prospects, this Zacks Rank #2 (Buy) stock is an attractive pick for investors at the moment. What’s Working in Favor? High Potent...

26
Yahoo FinanceMar 22

Why Is Genomic Health (GHDX) Down 4.8% Since Last Earnings Report?

Genomic Health (GHDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. It has been about a month since the last earnings report for Genomic Health (GHDX). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Genomic Health due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick loo...

24
Simply Wall StMar 12

Is Genomic Health’s (NASDAQ:GHDX) 206% Share Price Increase Well Justified?

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes to zero. But when you pick a company that is really flourishing, you can make more than 100%. For example, the Genomic Health, Inc. (NASDAQ:GHDX) share price has soared 206% in the last three years. Most would be happy with that. In the last week shares have slid back 1.9%. See our latest analysis for Genomic Health Given that Genomic Health only made minimal earnings in the last twelve mo...

88

Earnings

-$0.22
-$0.03
$0.16
$0.35
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.